Uni-Bio Science Group Limited Announces 2025 Annual Results

Record-Breaking Revenue of HK$586.2M and EPS Surged to HK$1.56 Cents Dividends Distributed for Two Consecutive Years Embarks on Innovation-Driven Transformation to Become a Global Pioneer in Regenerative Medicine HONG KONG SAR – EQS Newswire – 27 March 2026 – A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (“Uni-Bio Science”, together with its subsidiaries […]